Chronicle of Higher Education, February 28, 2022: Adderall, a stimulant medication often prescribed to treat attention deficit hyperactivity disorder, has been misused as a “study drug” on college campuses for years. According to the latest available annual national study, medications such as Adderall reached a 10-year low among college students in 2020.
Read More »We’re In The News
As a respected nonprofit health research center, our views are often quoted in the media, including newspapers, magazines, TV, radio, and websites. We also write articles and blogs for a number of different and highly respected newspapers, magazines, and popular websites, and we are published in prestigious medical journals and health policy publications. We frequently express our policy views in letters to government officials and public comments to federal agencies and we sometimes release statements or press releases on newsworthy issues.
Please e-mail info@center4research.org or call 202-223-4000 with your inquiries. We can assist you with scheduling interviews with the NCHR President, Dr. Diana Zuckerman, and other experts on our staff.
High Praise, Condemnation for CMS Aduhelm Coverage Plan
Medscape Medical News, February 16, 2022: Medicare has received a key endorsement and considerable support for its plan to restrict payment for the controversial Alzheimer’s disease drug aducanumab (Aduhelm) — but also drew pleas from other groups for more generous reimbursement of the drug.
Read More »She’s the reason Arizona has a law requiring surgeons to warn patients about the dangers of breast implants
Arizona News 12 NBC, February 22, 2022: Will this new law help women considering breast implants make informed medical decisions? The FDA took a step in the right direction but will doctors accurately inform their patients?
Read More »FDA’s agenda in limbo as Biden’s nominee stalls in Senate
Fox13, February 9, 2022: President Joe Biden’s pick to lead the Food and Drug Administration has stalled in the narrowly divided Senate, an unexpected setback that could delay decisions on electronic cigarettes and other high-profile health issues. Will all the publicity help Califf get confirmed, given the alternatives?
Read More »Biden’s ‘Cancer Moonshot’ Turns Toward Pollution
E&E News, February 3, 2022: President Biden made an emotional pledge to “end cancer as we know it” by reinvigorating the Cancer Moonshot Initiative he first launched in 2016, just one year after his son Beau succumbed to the disease. But experts, including us, point out that there isn’t enough focus on environmental causes of cancer.
Read More »